{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:37:36Z","timestamp":1790174256712,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12982-8","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:24:27Z","timestamp":1772727867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of multidrug resistant and ESBL producing Enterobacteriaceae among patients with urinary tract infections in Southwest Shewa, Ethiopia"],"prefix":"10.1186","volume":"26","author":[{"given":"Dirriba","family":"Diyana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bizuayehu Ketema","family":"Tafes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degefu","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejenie Shiferaw","family":"Teklu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"2","key":"12982_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41579-024-01092-4","volume":"23","author":"MR Timm","year":"2025","unstructured":"Timm MR, Russell SK, Hultgren SJ. Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nat Rev Microbiol. 2025;23(2):72\u201386.","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl 3","key":"12982_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1464-410X.2009.08371.x","volume":"103","author":"KS Coyne","year":"2009","unstructured":"Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, Aiyer LP. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009;103(3):4\u201311.","journal-title":"BJU Int"},{"issue":"3","key":"12982_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/cid\/ciae654","volume":"80","author":"SD Advani","year":"2025","unstructured":"Advani SD, Thaden JT, Perez R, Stair SL, Lee UJ, Siddiqui NY. Executive Summary: State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women. Clin Infect Dis. 2025;80(3):491\u20133.","journal-title":"Clin Infect Dis"},{"key":"12982_CR4","doi-asserted-by":"crossref","unstructured":"Maldonado-Barrag\u00e1n A, Mshana SE, Keenan K, Ke X, Gillespie SH, Stelling J, Maina J, Bazira J, Muhwezi I, Mushi MF, et al. Predominance of multidrug-resistant bacteria causing urinary tract infections among symptomatic patients in East Africa: a call for action. JAC-Antimicrobial Resist. 2024;6(1).","DOI":"10.1093\/jacamr\/dlae019"},{"key":"12982_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejim.2024.12.028","volume":"133","author":"L Onorato","year":"2025","unstructured":"Onorato L, Allegorico E, Macera M, Monari C, Migliaccio B, Nasta C, Florio MT, Sciorio R, Numis FG, Guiotto G, et al. Prevalence and impact of multidrug resistance in a cohort of patients admitted to emergency department for urinary tract-infections: The UTILY study, a prospective multicentre study. Eur J Intern Med. 2025;133:93\u20139.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"12982_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s44197-023-00105-4","volume":"13","author":"H Alghoraibi","year":"2023","unstructured":"Alghoraibi H, Asidan A, Aljawaied R, Almukhayzim R, Alsaydan A, Alamer E, Baharoon W, Masuadi E, Al Shukairi A, Layqah L, et al. Recurrent Urinary Tract Infection in Adult Patients, Risk Factors, and Efficacy of Low Dose Prophylactic Antibiotics Therapy. J Epidemiol Glob Health. 2023;13(2):200\u201311.","journal-title":"J Epidemiol Glob Health"},{"issue":"4","key":"12982_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0924-8579(00)00350-2","volume":"17","author":"TM Hooton","year":"2001","unstructured":"Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17(4):259\u201368.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"12982_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urols.2013.11.007","volume":"25","author":"M Glover","year":"2014","unstructured":"Glover M, Moreira CG, Sperandio V, Zimmern P. Recurrent urinary tract infections in healthy and nonpregnant women. Urol Sci. 2014;25(1):1\u20138.","journal-title":"Urol Sci"},{"issue":"10","key":"12982_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","volume":"17","author":"FME Wagenlehner","year":"2020","unstructured":"Wagenlehner FME, Bjerklund Johansen TE, Cai T, Koves B, Kranz J, Pilatz A, Tandogdu Z. Epidemiology, definition and treatment of complicated urinary tract infections. Nat Rev Urol. 2020;17(10):586\u2013600.","journal-title":"Nat Rev Urol"},{"issue":"3","key":"12982_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00345-021-03913-0","volume":"40","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Zhan J, Zhang K, Chen H, Cheng S. Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019. World J Urol. 2022;40(3):755\u201363.","journal-title":"World J Urol"},{"issue":"1","key":"12982_CR11","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1038\/s41598-025-89240-5","volume":"15","author":"Y He","year":"2025","unstructured":"He Y, Zhao J, Wang L, Han C, Yan R, Zhu P, Qian T, Yu S, Zhu X, He W. Epidemiological trends and predictions of urinary tract infections in the global burden of disease study 2021. Sci Rep. 2025;15(1):4702.","journal-title":"Sci Rep"},{"key":"12982_CR12","doi-asserted-by":"crossref","unstructured":"Carreno JJ, Tam IM, Meyers JL, Esterberg E, Candrilli SD, Lodise TP. Jr: longitudinal, nationwide, cohort study to assess incidence, outcomes, and costs associated with complicated urinary tract infection. Open Forum Infect Dis. 2019;6(11).","DOI":"10.1093\/ofid\/ofz446"},{"key":"12982_CR13","doi-asserted-by":"publisher","first-page":"888205","DOI":"10.3389\/fpubh.2022.888205","volume":"10","author":"X Yang","year":"2022","unstructured":"Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: A worldwide report. Front Public Health. 2022;10:888205.","journal-title":"Front Public Health"},{"issue":"1","key":"12982_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12866-025-03842-7","volume":"25","author":"D Kebede","year":"2025","unstructured":"Kebede D, Shiferaw Y, Kebede E, Demsiss W. Antimicrobial susceptibility and risk factors of uropathogens in symptomatic urinary tract infection cases at Dessie Referral Hospital, Ethiopia. BMC Microbiol. 2025;25(1):126.","journal-title":"BMC Microbiol"},{"key":"12982_CR15","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.2147\/IDR.S402279","volume":"16","author":"Y Gebretensaie","year":"2023","unstructured":"Gebretensaie Y, Atnafu A, Girma S, Alemu Y, Desta K. Prevalence of Bacterial Urinary Tract Infection, Associated Risk Factors, and Antimicrobial Resistance Pattern in Addis Ababa, Ethiopia: A Cross-Sectional Study. Infect Drug Resist. 2023;16:3041\u201350.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"12982_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12879-025-10788-8","volume":"25","author":"A Diriba","year":"2025","unstructured":"Diriba A, Gizaw S, Alemu F, Tesfaye K, Tesfaye E, Chali M, Jobir G. Prevalence, antimicrobial sensitivity patterns and associated factors of urinary tract infection among patients attending Nekemte Comprehensive Specialized Hospital, Western Ethiopia, 2024: a cross-sectional study. BMC Infect Dis. 2025;25(1):474.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"12982_CR17","first-page":"258517","volume":"2013","author":"T Khawcharoenporn","year":"2013","unstructured":"Khawcharoenporn T, Vasoo S, Singh K. Urinary tract infections due to multidrug-resistant Enterobacteriaceae: prevalence and risk factors in a Chicago emergency department. Emerg Med Int. 2013;2013(1):258517.","journal-title":"Emerg Med Int"},{"issue":"4","key":"12982_CR18","first-page":"131","volume":"10","author":"NPMD Nieko","year":"2022","unstructured":"Nieko NPMD, Morabandza CJ, Kaya-Ongoto MD, Kinavouidi DJK, Mbangou P-EB. First Detection of Fluoroquinolones and Aminoglycosides Resistance Genes in Multiresistant Enterobacteriaceae from Urinary Tract Infections. Am J Infect Dis Microbiol. 2022;10(4):131\u20138.","journal-title":"Am J Infect Dis Microbiol"},{"issue":"5","key":"12982_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"12982_CR20","doi-asserted-by":"crossref","unstructured":"Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y, Huang Y, Chi M. Urinary Tract infections caused by uropathogenic Escherichia coli: mechanisms of infection and treatment options. Int J Mol Sci. 2023;24(13).","DOI":"10.3390\/ijms241310537"},{"issue":"5","key":"12982_CR21","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/jac\/dkx488","volume":"73","author":"M Rozwandowicz","year":"2018","unstructured":"Rozwandowicz M, Brouwer MSM, Fischer J, Wagenaar JA, Gonzalez-Zorn B, Guerra B, Mevius DJ, Hordijk J. Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J Antimicrob Chemother. 2018;73(5):1121\u201337.","journal-title":"J Antimicrob Chemother"},{"key":"12982_CR22","doi-asserted-by":"crossref","unstructured":"Kiros T, Workineh L, Tiruneh T, Eyayu T, Damtie S, Belete D. Prevalence of extended-spectrum \u03b2-lactamase-producing enterobacteriaceae in ethiopia: a systematic review and meta-analysis. Int J microbiol. 2021:6669778.","DOI":"10.1155\/2021\/6669778"},{"issue":"7","key":"12982_CR23","doi-asserted-by":"publisher","first-page":"eaax1946","DOI":"10.1126\/sciadv.aax1946","volume":"5","author":"D Nagarajan","year":"2019","unstructured":"Nagarajan D, Roy N, Kulkarni O, Nanajkar N, Datey A, Ravichandran S, Thakur C, Aprameya TS, Sarma IV. \u03a976: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii. Sci Adv. 2019;5(7):eaax1946.","journal-title":"Sci Adv"},{"issue":"9","key":"12982_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","volume":"10","author":"KK Kumarasamy","year":"2010","unstructured":"Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597\u2013602.","journal-title":"Lancet Infect Dis"},{"key":"12982_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13756-015-0054-7","volume":"4","author":"S Eshetie","year":"2015","unstructured":"Eshetie S, Unakal C, Gelaw A, Ayelign B, Endris M, Moges F. Multidrug resistant and carbapenemase producing Enterobacteriaceae among patients with urinary tract infection at referral Hospital, Northwest Ethiopia. Antimicrob Resist Infect Control. 2015;4:12.","journal-title":"Antimicrob Resist Infect Control"},{"key":"12982_CR26","doi-asserted-by":"crossref","unstructured":"Agegnehu A, Worku M, Nigussie D, Lulu B, Tadesse BT. Pediatric febrile urinary tract infection caused by ESBL producing enterobacteriaceae species. Biomed Res Int. 2020:6679029.","DOI":"10.1155\/2020\/6679029"},{"key":"12982_CR27","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.2147\/IDR.S412350","volume":"16","author":"MG Gebremedhin","year":"2023","unstructured":"Gebremedhin MG, Weldu Y, Kahsay AG, Teame G, Adane K. Extended-Spectrum beta-Lactamase and Carbapenemase-Producing Gram-Negative Bacteria and Associated Factors Among Patients Suspected of Community and Hospital-Acquired Urinary Tract Infections at Ayder Comprehensive Specialized Hospital, Tigrai, Ethiopia. Infect Drug Resist. 2023;16:4025\u201337.","journal-title":"Infect Drug Resist"},{"issue":"5","key":"12982_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1086\/650482","volume":"50","author":"TM Hooton","year":"2010","unstructured":"Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect diseases: official publication Infect Dis Soc Am. 2010;50(5):625\u201363.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"issue":"1","key":"12982_CR29","first-page":"43","volume":"19","author":"J Kotrlik","year":"2001","unstructured":"Kotrlik J, Higgins C. Organizational research: Determining appropriate sample size in survey research appropriate sample size in survey research. Information technology, learning. Perform J. 2001;19(1):43.","journal-title":"Perform J"},{"key":"12982_CR30","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.2147\/IDR.S363988","volume":"15","author":"Z Sahle","year":"2022","unstructured":"Sahle Z, Engidaye G, Shenkute D, Metaferia Y, Shibabaw A. High Prevalence of Multi-Drug Resistance and Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Among Hospitalized Patients Presumptive for Bacterial Infection at Debre Berhan Comprehensive Specialized Hospital, Ethiopia. Infect Drug Resist. 2022;15:2639\u201356.","journal-title":"Infect Drug Resist"},{"key":"12982_CR31","doi-asserted-by":"crossref","unstructured":"Karah N, Rafei R, Elamin W, Ghazy A, Abbara A, Hamze M, Uhlin BE. Guideline for urine culture and biochemical identification of bacterial urinary pathogens in low-resource settings. Diagnostics (Basel, Switzerland). 2020;10(10).","DOI":"10.3390\/diagnostics10100832"},{"key":"12982_CR32","unstructured":"Lewis J, Melvin Weinstein F, Bobenchik A, Shelley Campeau M, Sharon Cullen D, Marcelo Galas R, Gold H, Romney Humphries F, Thomas Kirn F. Limbago BJAawcop: M100-Ed32 February 2022 Replaces M100-Ed31 performance standards for antimicrobial susceptibility testing suggested citation. 1986;1(688.0100)."},{"key":"12982_CR33","doi-asserted-by":"crossref","unstructured":"Macesic N, Uhlemann A-C, Peleg AYJTL. Multidrug-resistant gram-negative bacterial infections. 2025;405(10474):257\u201372.","DOI":"10.1016\/S0140-6736(24)02081-6"},{"issue":"1","key":"12982_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12905-021-01439-6","volume":"21","author":"AW Ejerssa","year":"2021","unstructured":"Ejerssa AW, Gadisa DA, Orjino TA. Prevalence of bacterial uropathogens and their antimicrobial susceptibility patterns among pregnant women in Eastern Ethiopia: hospital-based cross-sectional study. BMC Womens Health. 2021;21(1):291.","journal-title":"BMC Womens Health"},{"issue":"5","key":"12982_CR35","doi-asserted-by":"publisher","first-page":"e0296480","DOI":"10.1371\/journal.pone.0296480","volume":"19","author":"M Tilahun","year":"2024","unstructured":"Tilahun M, Fiseha M, Alebachew M, Gedefie A, Ebrahim E, Tesfaye M, Belete MA, Seid A, Gebretsadik D, Alemayehu E, et al. Uro-pathogens: Multidrug resistance and associated factors of community-acquired UTI among HIV patients attending antiretroviral therapy in Dessie Comprehensive Specialized Hospital, Northeast Ethiopia. PLoS ONE. 2024;19(5):e0296480.","journal-title":"PLoS ONE"},{"issue":"1","key":"12982_CR36","first-page":"e78094","volume":"17","author":"B Tuhamize","year":"2025","unstructured":"Tuhamize B, Tusubira D, Masembe C, Bessong PO, Byarugaba F, Bazira J. High Prevalence of Multidrug-Resistant Enterobacteriaceae Uropathogens Among Outpatients in Rural Southwestern Uganda. Cureus. 2025;17(1):e78094.","journal-title":"Cureus"},{"issue":"2","key":"12982_CR37","doi-asserted-by":"publisher","first-page":"e980","DOI":"10.52225\/narra.v4i2.980","volume":"4","author":"ME Prastiyanto","year":"2024","unstructured":"Prastiyanto ME, Darmawati S, Daryono BS, Retnaningrum E. Examining the prevalence and antimicrobial resistance profiles of multidrug-resistant bacterial isolates in wound infections from Indonesian patients. Narra J. 2024;4(2):e980.","journal-title":"Narra J"},{"issue":"11","key":"12982_CR38","doi-asserted-by":"publisher","first-page":"e0241984","DOI":"10.1371\/journal.pone.0241984","volume":"15","author":"SG Tekele","year":"2020","unstructured":"Tekele SG, Teklu DS, Tullu KD, Birru SK, Legese MH. Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia. PLoS ONE. 2020;15(11):e0241984.","journal-title":"PLoS ONE"},{"issue":"1","key":"12982_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13756-015-0085-0","volume":"4","author":"KK Yadav","year":"2015","unstructured":"Yadav KK, Adhikari N, Khadka R, Pant AD, Shah B. Multidrug resistant Enterobacteriaceae and extended spectrum \u03b2-lactamase producing Escherichia coli: a cross-sectional study in National Kidney Center, Nepal. Antimicrob Resist Infect Control. 2015;4(1):42.","journal-title":"Antimicrob Resist Infect Control"},{"key":"12982_CR40","doi-asserted-by":"crossref","unstructured":"Ojulong J, Gebru GN, Duduyemi B, Gbenda E, Janneh ML, Sharty J, Monteiro L, Kowuor D, Ameh S, Ogbuanu IU. Prevalence of antimicrobial resistance in klebsiella pneumoniae, enterobacter cloacae, and escherichia coli isolates among stillbirths and deceased under-five children in sierra leone: data from the child health and mortality prevention surveillance sites from 2019 to 2022. Microorganisms. 2024;12(8).","DOI":"10.3390\/microorganisms12081657"},{"issue":"1","key":"12982_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/CMR.00036-08","volume":"22","author":"GA Jacoby","year":"2009","unstructured":"Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009;22(1):161\u201382.","journal-title":"Clin Microbiol Rev"},{"key":"12982_CR42","doi-asserted-by":"crossref","unstructured":"Tebano G, Zaghi I, Cricca M, Cristini F. Antibiotic treatment of infections caused by AmpC-producing enterobacterales. Pharm (Basel Switzerland). 2024;12(5).","DOI":"10.3390\/pharmacy12050142"},{"issue":"4","key":"12982_CR43","doi-asserted-by":"publisher","first-page":"e0266878","DOI":"10.1371\/journal.pone.0266878","volume":"17","author":"D Kasew","year":"2022","unstructured":"Kasew D, Desalegn B, Aynalem M, Tila S, Diriba D, Afework B, Getie M, Biset S, Baynes HW. Antimicrobial resistance trend of bacterial uropathogens at the university of Gondar comprehensive specialized hospital, northwest Ethiopia: A 10 years retrospective study. PLoS ONE. 2022;17(4):e0266878.","journal-title":"PLoS ONE"},{"issue":"1","key":"12982_CR44","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12879-017-2743-8","volume":"17","author":"A Bitew","year":"2017","unstructured":"Bitew A, Molalign T, Chanie M. Species distribution and antibiotic susceptibility profile of bacterial uropathogens among patients complaining urinary tract infections. BMC Infect Dis. 2017;17(1):654.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"12982_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12879-017-2911-x","volume":"18","author":"WD Seifu","year":"2018","unstructured":"Seifu WD, Gebissa AD. Prevalence and antibiotic susceptibility of Uropathogens from cases of urinary tract infections (UTI) in Shashemene referral hospital, Ethiopia. BMC Infect Dis. 2018;18(1):30.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"12982_CR46","doi-asserted-by":"publisher","first-page":"ofac623","DOI":"10.1093\/ofid\/ofac623","volume":"9","author":"BW Trautner","year":"2022","unstructured":"Trautner BW, Kaye KS, Gupta V, Mulgirigama A, Mitrani-Gold FS, Scangarella-Oman NE, Yu K, Ye G, Joshi AV. Risk Factors Associated With Antimicrobial Resistance and Adverse Short-Term Health Outcomes Among Adult and Adolescent Female Outpatients With Uncomplicated Urinary Tract Infection. Open Forum Infect Dis. 2022;9(12):ofac623.","journal-title":"Open Forum Infect Dis"},{"key":"12982_CR47","doi-asserted-by":"crossref","unstructured":"Jensen MLV, Siersma V, S\u00f8es LM, Nicolaisdottir D, Bjerrum L, Holzknecht BJ. Prior antibiotic use increases risk of urinary tract infections caused by resistant escherichia coli among elderly in primary care: A case-control study. Antibiotics (Basel, Switzerland). 2022;11(10).","DOI":"10.3390\/antibiotics11101382"},{"issue":"2","key":"12982_CR48","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5811\/westjem.2017.12.35605","volume":"19","author":"SB Shipman","year":"2018","unstructured":"Shipman SB, Risinger CR, Evans CM, Gilbertson CD, Hogan DE. High Prevalence of Sterile Pyuria in the Setting of Sexually Transmitted Infection in Women Presenting to an Emergency Department. western J Emerg Med. 2018;19(2):282\u20136.","journal-title":"western J Emerg Med"},{"issue":"2","key":"12982_CR49","doi-asserted-by":"publisher","first-page":"e004020","DOI":"10.1136\/bmjopen-2013-004020","volume":"4","author":"AD Mebratie","year":"2014","unstructured":"Mebratie AD, Van de Poel E, Yilma Z, Abebaw D, Alemu G, Bedi AS. Healthcare-seeking behaviour in rural Ethiopia: evidence from clinical vignettes. BMJ open. 2014;4(2):e004020.","journal-title":"BMJ open"},{"issue":"9","key":"12982_CR50","doi-asserted-by":"publisher","first-page":"e0161014","DOI":"10.1371\/journal.pone.0161014","volume":"11","author":"B Begashaw","year":"2016","unstructured":"Begashaw B, Tessema F, Gesesew HA. Health Care Seeking Behavior in Southwest Ethiopia. PLoS ONE. 2016;11(9):e0161014.","journal-title":"PLoS ONE"},{"key":"12982_CR51","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2147\/IDR.S239092","volume":"13","author":"A Aklilu","year":"2020","unstructured":"Aklilu A, Manilal A, Ameya G, Woldemariam M, Siraj M. Gastrointestinal Tract Colonization Rate of Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Enterobacteriaceae and Associated Factors Among Hospitalized Patients in Arba Minch General Hospital, Arba Minch, Ethiopia. Infect Drug Resist. 2020;13:1517\u201326.","journal-title":"Infect Drug Resist"},{"key":"12982_CR52","doi-asserted-by":"crossref","unstructured":"Ameshe A, Engda T, Gizachew M. Antimicrobial resistance patterns, extended-spectrum beta-lactamase production, and associated risk factors of klebsiella species among UTI-suspected patients at Bahir Dar City, Northwest Ethiopia. Int. J Microbiol. 2022;2022:8216545.","DOI":"10.1155\/2022\/8216545"},{"issue":"1","key":"12982_CR53","first-page":"1","volume":"5","author":"SM Siraj","year":"2015","unstructured":"Siraj SM, Ali S, Wondafrash B. Extended-spectrum \u03b2-lactamase production in Klebsiella pneumoniae and Escherichia coli at Jimma University specialized hospital, south-west, Ethiopia. Mol Microbiol Res. 2015;5(1):1\u20139.","journal-title":"Mol Microbiol Res"},{"issue":"18","key":"12982_CR54","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1073\/pnas.1503141112","volume":"112","author":"TP Van Boeckel","year":"2015","unstructured":"Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, Teillant A, Laxminarayan R. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci USA. 2015;112(18):5649\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"12982_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"YY Liu","year":"2016","unstructured":"Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161\u20138.","journal-title":"Lancet Infect Dis"},{"key":"12982_CR56","doi-asserted-by":"crossref","unstructured":"Manyi-Loh C, Mamphweli S, Meyer E, Okoh A. Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications. Molecules (Basel, Switzerland). 2018;23(4).","DOI":"10.3390\/molecules23040795"},{"key":"12982_CR57","doi-asserted-by":"crossref","unstructured":"Heuer H, Smalla KJE. Horizontal gene transfer between bacteria. 2007;6:3\u201313.","DOI":"10.1051\/ebr:2007034"},{"key":"12982_CR58","doi-asserted-by":"crossref","unstructured":"Docquier JD, Mangani S. An update on \u03b2-lactamase inhibitor discovery and development. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. 2018;36:13\u201329.","DOI":"10.1016\/j.drup.2017.11.002"},{"issue":"1","key":"12982_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.48.1.1-14.2004","volume":"48","author":"R Bonnet","year":"2004","unstructured":"Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004;48(1):1\u201314.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"12982_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1517\/14656566.9.1.23","volume":"9","author":"DP Nicolau","year":"2008","unstructured":"Nicolau DP. Carbapenems: a potent class of antibiotics. Expert Opin Pharmacother. 2008;9(1):23\u201337.","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"12982_CR61","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1128\/AAC.00359-13","volume":"57","author":"S Tansarli Giannoula","year":"2013","unstructured":"Tansarli Giannoula S, Athanasiou S, Falagas Matthew E. Evaluation of Antimicrobial Susceptibility of Enterobacteriaceae Causing Urinary Tract Infections in Africa. Antimicrob Agents Chemother. 2013;57(8):3628\u201339.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"12982_CR62","doi-asserted-by":"publisher","first-page":"e0001421","DOI":"10.1371\/journal.pgph.0001421","volume":"3","author":"G Alemkere","year":"2023","unstructured":"Alemkere G, Teshome A, Temesgen G, Abebe G, Degefaw Y, Tilahun H, Getahun W, Girma E, Amogne W. Cefazolin access and use in Ethiopia: A policy implication. PLOS global public health. 2023;3(1):e0001421.","journal-title":"PLOS global public health"},{"issue":"3","key":"12982_CR63","doi-asserted-by":"publisher","first-page":"e390391","DOI":"10.1016\/j.cmi.2022.10.021","volume":"29","author":"A Baraz","year":"2023","unstructured":"Baraz A, Chowers M, Nevo D, Obolski U. The time-varying association between previous antibiotic use and antibiotic resistance. Clin Microbiol Infect. 2023;29(3):e390391\u20134.","journal-title":"Clin Microbiol Infect"},{"key":"12982_CR64","doi-asserted-by":"publisher","first-page":"258517","DOI":"10.1155\/2013\/258517","volume":"2013","author":"T Khawcharoenporn","year":"2013","unstructured":"Khawcharoenporn T, Vasoo S, Singh K. Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department. Emerg Med Int. 2013;2013:258517.","journal-title":"Emerg Med Int"},{"issue":"5","key":"12982_CR65","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41579-021-00649-x","volume":"20","author":"DGJ Larsson","year":"2022","unstructured":"Larsson DGJ, Flach C-F. Antibiotic resistance in the environment. Nat Rev Microbiol. 2022;20(5):257\u201369.","journal-title":"Nat Rev Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12982-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12982-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12982-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:03:44Z","timestamp":1776085424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12982-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12982"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12982-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants was reviewed and approved by the Research and Ethics Committee of the Medical Laboratory Sciences Department, College of Health Sciences, Addis Ababa University (approval no.: DRERC-490-20-MLS), and strictly adhered to the ethical principles of the World Medical Association Declaration of Helsinki. Informed written consent was obtained from adults aged\u2009\u2265\u200916 years (self-provided) and minors aged\u2009<\u200916 years (provided by parents or Legal Authorized Representatives [LARs]) after explaining the study objective. Only voluntary participants were enrolled. To protect data confidentiality, subjects were identified by unique codes, and only authorized personnel could access the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"754"}}